Tag: risk assessment

RACT Best Practices for Sponsors, CROs and Site Networks RACT Best Practices for Sponsors, CROs and Site Networks In the landscape of clinical trials, the Risk Assessment Categorization Tool (RACT) serves as a pivotal component for ensuring compliance and enhancing patient safety. As the industry shifts toward Risk-Based Monitoring (RBM) and remote oversight, it becomes…

Read More “RACT Best Practices for Sponsors, CROs and Site Networks” »

RACT for Decentralized and Hybrid Trial Designs RACT for Decentralized and Hybrid Trial Designs The clinical research landscape is evolving, especially with the rapid adoption of decentralized and hybrid trial designs. The introduction of the Risk Assessment Categorization Tool (RACT) provides a structured method for evaluating risks associated with clinical trials. In this comprehensive guide,…

Read More “RACT for Decentralized and Hybrid Trial Designs” »

Inspection Case Studies: When Weak RACT Drove Serious Quality Issues Inspection Case Studies: When Weak RACT Drove Serious Quality Issues In the rapidly evolving landscape of clinical trials, adhering to regulatory requirements and standards of quality becomes paramount. The advent of risk-based monitoring (RBM) and remote oversight has introduced new methodologies and tools, such as…

Read More “Inspection Case Studies: When Weak RACT Drove Serious Quality Issues” »

Linking RACT to CtQ Factors, QTLs and Vendor Oversight In the evolving landscape of clinical trials, optimizing oversight mechanisms is imperative for ensuring compliance and data integrity. This step-by-step guide focuses on the Risk Assessment Categorization Tool (RACT), its correlation with Critical to Quality (CtQ) factors, Quality Tolerance Limits (QTLs), and the significance of vendor…

Read More “Linking RACT to CtQ Factors, QTLs and Vendor Oversight” »

Refreshing RACT Throughout the Study Lifecycle: When and How The Risk Assessment Categorization Tool (RACT) plays a crucial role in enhancing clinical trial oversight through effective risk-based monitoring (RBM). Addressing the need for a structured approach to risk assessments, RACT is an essential tool for clinical operations, regulatory affairs, and medical affairs professionals engaged in…

Read More “Refreshing RACT Throughout the Study Lifecycle: When and How” »

Regulatory Expectations for RACT Documentation in RBM Submissions Regulatory Expectations for RACT Documentation in RBM Submissions In the rapidly evolving landscape of clinical trials, effective monitoring strategies are pivotal for ensuring data integrity and patient safety. The Risk-Based Monitoring (RBM) approach, particularly in conjunction with the Risk Assessment Categorization Tool (RACT), has emerged as a…

Read More “Regulatory Expectations for RACT Documentation in RBM Submissions” »

Digital RACT Tools: Configuration, Dashboards and Governance In the evolving landscape of clinical research management, the utilization of Digital Risk Assessment Categorization Tools (RACT) is becoming increasingly critical. This article provides a comprehensive step-by-step guide focused on configuring, managing dashboards, and establishing governance around RACT tools. Professional roles such as clinical operations, regulatory affairs, and…

Read More “Digital RACT Tools: Configuration, Dashboards and Governance” »

Integrating RACT Outputs With Monitoring Plans and KRIs The ongoing transformation of clinical trials towards risk-based monitoring (RBM) requires a robust understanding of how to effectively use various tools and methodologies. One key element of RBM is the Risk Assessment Categorization Tool (RACT), which allows clinical trial professionals, particularly in gilead clinical trials, to identify,…

Read More “Integrating RACT Outputs With Monitoring Plans and KRIs” »

Customizing RACT Templates for Oncology, Rare Disease and Device Trials Customizing RACT Templates for Oncology, Rare Disease and Device Trials The customization of Risk Assessment Categorization Tool (RACT) templates is crucial for optimizing clinical trial oversight, particularly in fields such as oncology, rare diseases, and medical devices. The implementation of a tailored RACT framework enhances…

Read More “Customizing RACT Templates for Oncology, Rare Disease and Device Trials” »

Common RACT Mistakes That Undermine Risk-Based Monitoring Programs Common RACT Mistakes That Undermine Risk-Based Monitoring Programs Risk-Based Monitoring (RBM) has gained significant traction in clinical research as professionals seek to enhance study oversight while managing resources efficiently. The Risk Assessment Categorization Tool (RACT) plays a vital role in identifying potential risks in clinical trials. However,…

Read More “Common RACT Mistakes That Undermine Risk-Based Monitoring Programs” »